Semnur PharmaceuticalsSMNR
13F holders, Q2 2026 (June 30)2holders
$0.50avg. 13F price*
At the end of Q2 2026, 2 institutions reported holding Semnur Pharmaceuticals Inc. (SMNR) in their 13F filings. The largest holders were GAMMA Investing LLC ($58) and Rhumbline Advisers ($15).
- Company
- Semnur Pharmaceuticals Inc.
- CUSIP
- 81686G105
- Latest filing quarter
- Q2 2026
Total Exit/New Position Q2 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $73 |
| Exits | 0 | $0 |
Ownership 2 holders
| GAMMA Investing LLC | 0.00% | New | 116 | $58 |
| Rhumbline Advisers | 0.00% | New | 30 | $15 |
"% of holder's portfolio" is SMNR's weight in each manager's 13F, not the share of Semnur Pharmaceuticals Inc. the manager owns.